Clinical Trials
20 trialsNCT02059499 2025-07-23
Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions
AIDS Malignancy Consortium
Phase 3 Completed
NCT03196180 2025-04-08
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed
NCT06686043 2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2 Recruiting
NCT02135419 2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3 Completed
NCT00799110 2024-06-11
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
Beth Israel Deaconess Medical Center
Phase 2 Active not recruiting
NCT02864147 2024-05-02
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Yale University
Phase 2 Completed
NCT00788164 2023-08-31
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT03180684 2023-08-25
Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)
Inovio Pharmaceuticals
Phase 2 Completed
NCT04859361 2021-05-03
Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ
University Medical Centre Maribor
Phase NA Unknown
NCT03233412 2021-02-17
Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions
Barretos Cancer Hospital
Phase 2 Completed
NCT02917746 2018-08-16
TOPIC-3
Maastricht University Medical Center
Phase NA Unknown
NCT02329171 2018-08-15
TOPIC
Maastricht University Medical Center
Phase 3 Terminated
NCT00988559 2018-07-09
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00504023 2018-06-06
Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02669459 2018-02-06
TopIC-2
Erasmus Medical Center
Phase 3 Unknown
NCT03206138 2017-07-02
Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.
Seoul St. Mary's Hospital
Phase NA Unknown
NCT02130323 2017-06-27
Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix
United States Naval Medical Center, San Diego
Phase 2/3 Completed
NCT01283763 2016-11-01
ITIC2
Medical University of Vienna
Phase 3 Terminated
NCT00031759 2016-07-13
Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00941252 2011-01-24
ITIC
Medical University of Vienna
Phase 2/3 Completed